On Tuesday, Aptevo Therapeutics Inc (NASDAQ: APVO) was -3.65% drop from the session before settling in for the closing price of $1.37. A 52-week range for APVO has been $1.32 – $298.00.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 80.96%. When this article was written, the company’s average yearly earnings per share was at 99.69%. With a float of $16.83 million, this company’s outstanding shares have now reached $16.85 million.
Aptevo Therapeutics Inc (APVO) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Aptevo Therapeutics Inc stocks. The insider ownership of Aptevo Therapeutics Inc is 0.10%, while institutional ownership is 7.19%. The most recent insider transaction that took place on Nov 10 ’25, was worth 20,134. In this transaction Director of this company bought 13,513 shares at a rate of $1.49, taking the stock ownership to the 13,514 shares.
Aptevo Therapeutics Inc (APVO) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -178.8 earnings per share (EPS) during the time that was less than consensus figure (set at -155) by -23.8.
According to the Wall Street analysts, stocks earnings will be around 99.69% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 90.39% during the next five years compared to 80.96% growth over the previous five years of trading.
Aptevo Therapeutics Inc (NASDAQ: APVO) Trading Performance Indicators
You can see what Aptevo Therapeutics Inc (APVO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.03.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -185.07, a number that is poised to hit -0.45 in the next quarter and is forecasted to reach -1.60 in one year’s time.
Technical Analysis of Aptevo Therapeutics Inc (APVO)
Compared to the last year’s volume of 2.37 million, its volume of 0.64 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 14.48%.
During the past 100 days, Aptevo Therapeutics Inc’s (APVO) raw stochastic average was set at 2.46%, which indicates a significant decrease from 16.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0879 in the past 14 days, which was lower than the 0.1514 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5288, while its 200-day Moving Average is $15.5412. Nevertheless, the first resistance level for the watch stands at $1.3567 in the near term. At $1.3933, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.4367. If the price goes on to break the first support level at $1.2767, it is likely to go to the next support level at $1.2333. Should the price break the second support level, the third support level stands at $1.1967.
Aptevo Therapeutics Inc (NASDAQ: APVO) Key Stats
There are 16,850K outstanding shares of the company, which has a market capitalization of 22.25 million. As of now, sales total 0 K while income totals -24,130 K. Its latest quarter income was 0 K while its last quarter net income were -7,550 K.
